MEG3 and breast cancer: For example, MEG3 is downregulated in both retinoblastoma and BC cells, and its overexpression suppresses proliferation while inactivating the PI3K/Akt/mTOR pathway, thereby reducing migration and enhancing apoptosis [25, 26].